 | • レポートコード：MRC2312MG00422 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、63ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の整形外科用生物製剤製品市場規模と予測を収録しています。・世界の整形外科用生物製剤製品市場：売上、2018年-2023年、2024年-2029年 ・世界の整形外科用生物製剤製品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の整形外科用生物製剤製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「骨成長促進剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 整形外科用生物製剤製品のグローバル主要企業は、Stryker、 Zimmer Biomet、 Smith+Nephew、 Heraeus Holding GmbH、 Invibio Ltd.、 Evonik Industries、 DePuy Synthes、 Globus Medical Inc.、 Orthofixなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、整形外科用生物製剤製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の整形外科用生物製剤製品市場：タイプ別、2018年-2023年、2024年-2029年 世界の整形外科用生物製剤製品市場：タイプ別市場シェア、2022年 ・骨成長促進剤、粘液補給、幹細胞、その他 世界の整形外科用生物製剤製品市場：用途別、2018年-2023年、2024年-2029年 世界の整形外科用生物製剤製品市場：用途別市場シェア、2022年 ・病院、整形外科クリニック、外来手術センター 世界の整形外科用生物製剤製品市場：地域・国別、2018年-2023年、2024年-2029年 世界の整形外科用生物製剤製品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における整形外科用生物製剤製品のグローバル売上、2018年-2023年 ・主要企業における整形外科用生物製剤製品のグローバル売上シェア、2022年 ・主要企業における整形外科用生物製剤製品のグローバル販売量、2018年-2023年 ・主要企業における整形外科用生物製剤製品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Stryker、 Zimmer Biomet、 Smith+Nephew、 Heraeus Holding GmbH、 Invibio Ltd.、 Evonik Industries、 DePuy Synthes、 Globus Medical Inc.、 Orthofix ************************************************************* ・調査・分析レポートの概要 整形外科用生物製剤製品市場の定義 市場セグメント 世界の整形外科用生物製剤製品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の整形外科用生物製剤製品市場規模 世界の整形外科用生物製剤製品市場規模：2022年 VS 2029年 世界の整形外科用生物製剤製品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの整形外科用生物製剤製品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の整形外科用生物製剤製品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：骨成長促進剤、粘液補給、幹細胞、その他 整形外科用生物製剤製品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、整形外科クリニック、外来手術センター 整形外科用生物製剤製品の用途別グローバル売上・予測 ・地域別市場分析 地域別整形外科用生物製剤製品市場規模 2022年と2029年 地域別整形外科用生物製剤製品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Stryker、 Zimmer Biomet、 Smith+Nephew、 Heraeus Holding GmbH、 Invibio Ltd.、 Evonik Industries、 DePuy Synthes、 Globus Medical Inc.、 Orthofix ... |
This research report provides a comprehensive analysis of the Orthoapedics Biologics Products market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Orthoapedics Biologics Products market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Orthoapedics Biologics Products, challenges faced by the industry, and potential opportunities for market players.
The global Orthoapedics Biologics Products market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Orthoapedics Biologics Products market presents opportunities for various stakeholders, including Hospital, Orthopedic Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Orthoapedics Biologics Products market. Additionally, the growing consumer demand present avenues for market expansion.
The global Orthoapedics Biologics Products market was valued at US$ 406.5 million in 2022 and is projected to reach US$ 542.1 million by 2029, at a CAGR of 4.3% during the forecast period.
Key Features:
The research report on the Orthoapedics Biologics Products market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Orthoapedics Biologics Products market.
Market Overview: The report provides a comprehensive overview of the Orthoapedics Biologics Products market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Bone Growth Stimulator, Viscosupplementation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Orthoapedics Biologics Products market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Orthoapedics Biologics Products market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Orthoapedics Biologics Products market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Orthoapedics Biologics Products market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Orthoapedics Biologics Products market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Orthoapedics Biologics Products market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Orthoapedics Biologics Products, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Orthoapedics Biologics Products market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Orthoapedics Biologics Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Bone Growth Stimulator
Viscosupplementation
Stem Cell
Others
Market segment by Application
Hospital
Orthopedic Clinic
Ambulatory Surgery Center
Global Orthoapedics Biologics Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Stryker
Zimmer Biomet
Smith+Nephew
Heraeus Holding GmbH
Invibio Ltd.
Evonik Industries
DePuy Synthes
Globus Medical Inc.
Orthofix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orthoapedics Biologics Products, market overview.
Chapter 2: Global Orthoapedics Biologics Products market size in revenue.
Chapter 3: Detailed analysis of Orthoapedics Biologics Products company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orthoapedics Biologics Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Orthoapedics Biologics Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orthoapedics Biologics Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orthoapedics Biologics Products Overall Market Size
2.1 Global Orthoapedics Biologics Products Market Size: 2022 VS 2029
2.2 Global Orthoapedics Biologics Products Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orthoapedics Biologics Products Players in Global Market
3.2 Top Global Orthoapedics Biologics Products Companies Ranked by Revenue
3.3 Global Orthoapedics Biologics Products Revenue by Companies
3.4 Top 3 and Top 5 Orthoapedics Biologics Products Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orthoapedics Biologics Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthoapedics Biologics Products Players in Global Market
3.6.1 List of Global Tier 1 Orthoapedics Biologics Products Companies
3.6.2 List of Global Tier 2 and Tier 3 Orthoapedics Biologics Products Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Orthoapedics Biologics Products Market Size Markets, 2022 & 2029
4.1.2 Bone Growth Stimulator
4.1.3 Viscosupplementation
4.1.4 Stem Cell
4.1.5 Others
4.2 By Type – Global Orthoapedics Biologics Products Revenue & Forecasts
4.2.1 By Type – Global Orthoapedics Biologics Products Revenue, 2018-2023
4.2.2 By Type – Global Orthoapedics Biologics Products Revenue, 2024-2029
4.2.3 By Type – Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Orthoapedics Biologics Products Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Orthopedic Clinic
5.1.4 Ambulatory Surgery Center
5.2 By Application – Global Orthoapedics Biologics Products Revenue & Forecasts
5.2.1 By Application – Global Orthoapedics Biologics Products Revenue, 2018-2023
5.2.2 By Application – Global Orthoapedics Biologics Products Revenue, 2024-2029
5.2.3 By Application – Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Orthoapedics Biologics Products Market Size, 2022 & 2029
6.2 By Region – Global Orthoapedics Biologics Products Revenue & Forecasts
6.2.1 By Region – Global Orthoapedics Biologics Products Revenue, 2018-2023
6.2.2 By Region – Global Orthoapedics Biologics Products Revenue, 2024-2029
6.2.3 By Region – Global Orthoapedics Biologics Products Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Orthoapedics Biologics Products Revenue, 2018-2029
6.3.2 US Orthoapedics Biologics Products Market Size, 2018-2029
6.3.3 Canada Orthoapedics Biologics Products Market Size, 2018-2029
6.3.4 Mexico Orthoapedics Biologics Products Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Orthoapedics Biologics Products Revenue, 2018-2029
6.4.2 Germany Orthoapedics Biologics Products Market Size, 2018-2029
6.4.3 France Orthoapedics Biologics Products Market Size, 2018-2029
6.4.4 U.K. Orthoapedics Biologics Products Market Size, 2018-2029
6.4.5 Italy Orthoapedics Biologics Products Market Size, 2018-2029
6.4.6 Russia Orthoapedics Biologics Products Market Size, 2018-2029
6.4.7 Nordic Countries Orthoapedics Biologics Products Market Size, 2018-2029
6.4.8 Benelux Orthoapedics Biologics Products Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Orthoapedics Biologics Products Revenue, 2018-2029
6.5.2 China Orthoapedics Biologics Products Market Size, 2018-2029
6.5.3 Japan Orthoapedics Biologics Products Market Size, 2018-2029
6.5.4 South Korea Orthoapedics Biologics Products Market Size, 2018-2029
6.5.5 Southeast Asia Orthoapedics Biologics Products Market Size, 2018-2029
6.5.6 India Orthoapedics Biologics Products Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Orthoapedics Biologics Products Revenue, 2018-2029
6.6.2 Brazil Orthoapedics Biologics Products Market Size, 2018-2029
6.6.3 Argentina Orthoapedics Biologics Products Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Orthoapedics Biologics Products Revenue, 2018-2029
6.7.2 Turkey Orthoapedics Biologics Products Market Size, 2018-2029
6.7.3 Israel Orthoapedics Biologics Products Market Size, 2018-2029
6.7.4 Saudi Arabia Orthoapedics Biologics Products Market Size, 2018-2029
6.7.5 UAE Orthoapedics Biologics Products Market Size, 2018-2029
7 Orthoapedics Biologics Products Companies Profiles
7.1 Stryker
7.1.1 Stryker Company Summary
7.1.2 Stryker Business Overview
7.1.3 Stryker Orthoapedics Biologics Products Major Product Offerings
7.1.4 Stryker Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.1.5 Stryker Key News & Latest Developments
7.2 Zimmer Biomet
7.2.1 Zimmer Biomet Company Summary
7.2.2 Zimmer Biomet Business Overview
7.2.3 Zimmer Biomet Orthoapedics Biologics Products Major Product Offerings
7.2.4 Zimmer Biomet Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.2.5 Zimmer Biomet Key News & Latest Developments
7.3 Smith+Nephew
7.3.1 Smith+Nephew Company Summary
7.3.2 Smith+Nephew Business Overview
7.3.3 Smith+Nephew Orthoapedics Biologics Products Major Product Offerings
7.3.4 Smith+Nephew Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.3.5 Smith+Nephew Key News & Latest Developments
7.4 Heraeus Holding GmbH
7.4.1 Heraeus Holding GmbH Company Summary
7.4.2 Heraeus Holding GmbH Business Overview
7.4.3 Heraeus Holding GmbH Orthoapedics Biologics Products Major Product Offerings
7.4.4 Heraeus Holding GmbH Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.4.5 Heraeus Holding GmbH Key News & Latest Developments
7.5 Invibio Ltd.
7.5.1 Invibio Ltd. Company Summary
7.5.2 Invibio Ltd. Business Overview
7.5.3 Invibio Ltd. Orthoapedics Biologics Products Major Product Offerings
7.5.4 Invibio Ltd. Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.5.5 Invibio Ltd. Key News & Latest Developments
7.6 Evonik Industries
7.6.1 Evonik Industries Company Summary
7.6.2 Evonik Industries Business Overview
7.6.3 Evonik Industries Orthoapedics Biologics Products Major Product Offerings
7.6.4 Evonik Industries Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.6.5 Evonik Industries Key News & Latest Developments
7.7 DePuy Synthes
7.7.1 DePuy Synthes Company Summary
7.7.2 DePuy Synthes Business Overview
7.7.3 DePuy Synthes Orthoapedics Biologics Products Major Product Offerings
7.7.4 DePuy Synthes Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.7.5 DePuy Synthes Key News & Latest Developments
7.8 Globus Medical Inc.
7.8.1 Globus Medical Inc. Company Summary
7.8.2 Globus Medical Inc. Business Overview
7.8.3 Globus Medical Inc. Orthoapedics Biologics Products Major Product Offerings
7.8.4 Globus Medical Inc. Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.8.5 Globus Medical Inc. Key News & Latest Developments
7.9 Orthofix
7.9.1 Orthofix Company Summary
7.9.2 Orthofix Business Overview
7.9.3 Orthofix Orthoapedics Biologics Products Major Product Offerings
7.9.4 Orthofix Orthoapedics Biologics Products Revenue in Global Market (2018-2023)
7.9.5 Orthofix Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer